Trial site
First Oc Dermatology Research Inc
- 13running trials
- 15closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Psoriasis11 trials
- Atopic dermatitis (eczema)6 trials
- Chronic spontaneous urticaria3 trials
- Hidradenitis suppurativa3 trials
- Vitiligo3 trials
- Obesity2 trials
- Psoriatic arthritis2 trials
- Alopecia areata1 trial
- Phase
- Phase 316 trials
- Phase 210 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting7 trials
- Recruiting4 trials
- Terminated4 trials
- Not yet recruiting2 trials
- Lead sponsor
- Pfizer7 trials
- Takeda6 trials
- Eli Lilly and Company4 trials
- Alumis Inc2 trials
- Incyte Corporation2 trials
- and 7 more
Running trials
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Recruiting
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Psoriasis3 recruiting
- Atopic dermatitis (eczema)2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Obesity1 recruiting
- Psoriatic arthritis1 recruiting
Closed trials
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Completed
Terminated
Completed
A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed
Completed
Terminated
Completed
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Completed
Completed
Terminated
Terminated
Completed
Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)
Completed
Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026